文献速递创伤与烧伤重症综合管理与镇静镇痛

使用TEG 6s快速床旁检测和分类直接口服抗凝药:对创伤和急诊外科的意义

Rapid point-of-care detection and classification of direct-acting oral anticoagulants with the TEG 6s: Implications for trauma and acute care surgery.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论TEG 6s床旁黏弹性检测可高敏高特异检测并分类直接口服抗凝药,有助于判断创伤患者是否需要逆转及手术时机。

本研究为观察性、前瞻性、开放标签、多中心研究,用床旁黏弹性检测分析接受与未接受直接口服抗凝药治疗的患者及健康志愿者的血样。用抗Xa和直接凝血酶抑制试验建立TEG 6s参数参考范围:抗Xa试验R参数0.6至1.5分钟,直接凝血酶抑制试验R参数1.6至2.5分钟。以此算法在2.5分钟或更短时检测Xa抑制剂和直接凝血酶抑制剂的敏感性分别为98.3%和100%,特异性100%。两类直接口服抗凝药在药物谷浓度时亦可检出。作者认为该工具可用于更好地判断创伤和急诊外科患者是否需要逆转并指导急性期最佳手术时机。

要点

  • TEG 6s抗Xa试验R参数参考范围0.6至1.5分钟,直接凝血酶抑制试验R参数参考范围1.6至2.5分钟。
  • 用上述范围在2.5分钟或更短时识别Xa抑制剂的敏感性98.3%、直接凝血酶抑制剂的敏感性100%,特异性100%。
  • 两类直接口服抗凝药在给药间期谷浓度时仍可被检测到。
  • 该检测可帮助判断创伤和急诊外科患者是否需要逆转及指导急性期手术时机。

适用人群与场景

  • 接受直接口服抗凝药治疗且受伤的创伤患者,以及未接受直接口服抗凝药治疗的患者和健康志愿者。

诊断标准与关键阈值

  • TEG 6s抗Xa试验R参数参考范围0.6至1.5分钟,直接凝血酶抑制试验R参数参考范围1.6至2.5分钟。
  • 识别算法在2.5分钟或更短时判定直接口服抗凝药类别。

研究设计与关键结果

  • 观察性、前瞻性、开放标签、多中心研究,用床旁黏弹性检测分析接受与未接受直接口服抗凝药治疗的患者及健康志愿者血样。
  • 抗Xa试验R参数参考范围0.6至1.5分钟,直接凝血酶抑制试验R参数参考范围1.6至2.5分钟。
  • 识别算法在2.5分钟或更短时检测Xa抑制剂的敏感性98.3%、直接凝血酶抑制剂的敏感性100%,特异性100%。
  • 两类直接口服抗凝药在药物谷浓度时亦可检出。

证据类型、等级与局限

  • 预后与流行病学研究,证据等级II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,TEG 6s床旁黏弹性检测可用于更好地判断创伤和急诊外科患者是否需要逆转,并指导急性期最佳手术时机。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The trauma patient on direct oral anticoagulant (DOAC) therapy preinjury presents a challenge in trauma and acute care surgery. Our understanding of these patients is extrapolated from vitamin K antagonists. However, DOACs have different mechanisms of action, effects on laboratory coagulation assays, and reversal strategies. Rapid identification of DOACs in the blood will allow timely reversal of factor Xa inhibitors and direct thrombin inhibitors when necessary. The present study evaluated viscoelastic testing to detect and classify DOACs in patient blood samples.

METHODS: This observational, prospective, open-label, multicenter study used point-of-care viscoelastic testing to analyze blood samples taken from patients with and without DOAC treatment, and healthy volunteers. Antifactor Xa and direct thrombin inhibition (DTI) assays were used to establish reference ranges for viscoelastic testing parameters on the TEG 6s system. These ranges were applied to produce a DOAC identification algorithm for patient blood samples. Internal consistency of the measurements, as well as algorithm sensitivity and specificity, was evaluated.

RESULTS: Using the TEG 6s system, the R parameter reference range was 0.6 minutes to 1.5 minutes for the Antifactor Xa assay and 1.6 minutes to 2.5 minutes for the DTI assay. Our identification algorithm using these ranges for 2.5 minutes or less has sensitives of 98.3% and 100% for factor Xa inhibitor and direct thrombin inhibitor detection, respectively. Specificity was 100%. Both classes of DOAC were detectable, even when samples were collected during the "trough" between doses of medication.

CONCLUSION: Point-of-care viscoelastic testing with TEG 6s can detect and classify DOACs with high sensitivity and specificity. This tool can be used to better determine the need for reversal in trauma and acute care surgery patients and guide optimal surgical timing in the acute setting.

LEVEL OF EVIDENCE: Prognostic and epidemiological study, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Dias JD, Lopez-Espina CG, Ippolito J, et al. Rapid point-of-care detection and classification of direct-acting oral anticoagulants with the TEG 6s: Implications for trauma and acute care surgery. J Trauma Acute Care Surg. 2019. PMID: 31045726. doi:10.1097/TA.0000000000002357

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。